Alemtuzumab induction in kidney transplant recipients

被引:0
|
作者
机构
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:471 / 471
相关论文
共 50 条
  • [41] Alemtuzumab induction with tacrolimus monotherapy in 25 pediatric renal transplant recipients
    Sung, Jennifer
    Barry, John M.
    Jenkins, Randy
    Rozansky, David
    Iragorri, Sandra
    Conlin, Michael
    Al-Uzri, Amira
    PEDIATRIC TRANSPLANTATION, 2013, 17 (08) : 718 - 725
  • [42] Immune Profile of Pediatric Renal Transplant Recipients following Alemtuzumab Induction
    De Serres, Sacha A.
    Mfarrej, Bechara G.
    Magee, Ciara N.
    Benitez, Fanny
    Ashoor, Isa
    Sayegh, Mohamed H.
    Harmon, William E.
    Najafian, Nader
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (01): : 174 - 182
  • [43] BK Virus Infection With Alemtuzumab Induction in Pediatric Kidney Transplant Recipients. A Single Center Experience.
    Al-Uzri, A.
    Patel, T.
    Nolt, D.
    Jenkins, R.
    Iragorri, S.
    Rozansky, D.
    Munar, M.
    TRANSPLANTATION, 2014, 98 : 502 - 502
  • [44] Alemtuzumab induction therapy in HIV-positive renal transplant recipients
    Mclean, Florence E.
    Gathogo, Esther
    Goodall, Dawn
    Jones, Rachael
    Kinlcoh, Sabine
    Post, Frank A.
    AIDS, 2017, 31 (07) : 1047 - 1048
  • [45] Comparison of Alemtuzumab Versus Basiliximab Induction Therapy in Elderly Kidney Transplant Recipients: A Single-Center Experience
    Yakubu, Idris
    Ravichandran, Bharath
    Sparkes, Tracy
    Barth, Rolf N.
    Haririan, Abdolreza
    Masters, Brian
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (02) : 199 - 206
  • [46] Donor Specific Antibody Development in Kidney Transplant Recipients with or without Delayed Graft Function Receiving Alemtuzumab Induction
    Sparkes, T.
    Haririan, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S693 - S693
  • [47] HAEMATOLOGICAL AUTOIMMUNE DISORDERS FOLLOWING ALEMTUZUMAB INDUCTION FOR KIDNEY TRANSPLANT
    Gleeson, Sarah
    Kousios, Andreas
    Luqmani, Asad
    Ademokun, Christine
    Cooper, Nichola
    Charif, Rawya
    TRANSPLANT INTERNATIONAL, 2021, 34 : 51 - 51
  • [48] Alemtuzumab preconditioning and tacrolimus monotherapy in pediatric kidney transplant recipients.
    Shapiro, Ron
    El Jis, Demetrius
    Tan, Henkie P.
    Tz, Michael L. Mori
    Basu, Amit
    Vats, AbhayN.
    Kayler, Liise K.
    Erkan, Elif
    McFeaters, Corde G.
    James, Gerri
    Grosso, Mary J.
    Zeevi, Adriana
    Gray, Edward A.
    Marcos, Amadeo
    Starzl, Thomas E.
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 54 - 54
  • [49] Personalized anti-rejection therapy with alemtuzumab for kidney transplant recipients
    Hesselink, Dennis A.
    Hullegie-Peelen, Daphne M.
    van Vugt, Lukas K.
    PHARMACOGENOMICS, 2022, 23 (10) : 567 - 570
  • [50] Outcomes Associated with Steroid Avoidance and Alemtuzumab among Kidney Transplant Recipients
    Serrano, Oscar K.
    Friedmann, Patricia
    Ahsanuddin, Sayeeda
    Millan, Carlos
    Ben-Yaacov, Almog
    Kayler, Liise K.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (11): : 2030 - 2038